EDITORIAL
Published on 18 Oct 2022
Editorial: Central nervous system acting drugs-molecular mechanisms of neuroprotection and neurodegeneration
doi 10.3389/fnins.2022.1060515
- 977 views
- 1 citation
- Frontiers in Neuroscience
- Neuropharmacology
- Research Topics
- Central nervous system acting drugs – molecular mechanisms of neuroprotection and neurodegeneration
Central nervous system acting drugs – molecular mechanisms of neuroprotection and neurodegeneration
19k
Total Downloads
61k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 16 Sep 2022
The role of hypothalamic endoplasmic reticulum stress in schizophrenia and antipsychotic-induced weight gain: A narrative review
doi 10.3389/fnins.2022.947295
- 3,807 views
- 10 citations
SYSTEMATIC REVIEW
Published on 07 Sep 2022
Therapeutic effects and long-term outcomes of HMGB1-targeted therapy in rats and mice with traumatic spinal cord injury: A systematic review and meta-analysis
doi 10.3389/fnins.2022.968791
- 1,324 views
- 1 citation
ORIGINAL RESEARCH
Published on 06 Sep 2022
EGCG protects the mouse brain against cerebral ischemia/reperfusion injury by suppressing autophagy via the AKT/AMPK/mTOR phosphorylation pathway
doi 10.3389/fphar.2022.921394
- 2,499 views
- 10 citations
ORIGINAL RESEARCH
Published on 30 Aug 2022
Akebia saponin D protects hippocampal neurogenesis from microglia-mediated inflammation and ameliorates depressive-like behaviors and cognitive impairment in mice through the PI3K-Akt pathway
doi 10.3389/fphar.2022.927419
- 3,561 views
- 26 citations
SYSTEMATIC REVIEW
Published on 29 Aug 2022
Effect of ouabain on calcium signaling in rodent brain: A systematic review of in vitro studies
doi 10.3389/fphar.2022.916312
- 2,407 views
- 1 citation
STUDY PROTOCOL
Published on 11 May 2022
Potential Treat-to-Target Approach for Methamphetamine Use Disorder: A Pilot Study of Adenosine 2A Receptor Antagonist With Positron Emission Tomography
doi 10.3389/fphar.2022.820447
- 1,171 views
ORIGINAL RESEARCH
Published on 23 Mar 2022
Alpha-Asaronol Alleviates Dysmyelination by Enhancing Glutamate Transport Through the Activation of PPARγ-GLT-1 Signaling in Hypoxia-Ischemia Neonatal Rats
doi 10.3389/fphar.2022.766744
- 2,079 views
- 9 citations
ORIGINAL RESEARCH
Published on 07 Mar 2022
A Loading Dose of Dexmedetomidine With Constant Infusion Inhibits Intraoperative Neuromonitoring During Thoracic Spinal Decompression Surgery: A Randomized Prospective Study
doi 10.3389/fphar.2022.840320
- 3,546 views
- 7 citations
ORIGINAL RESEARCH
Published on 14 Feb 2022
Blood Glutamate Scavenging With Pyruvate as a Novel Preventative and Therapeutic Approach for Depressive-Like Behavior Following Traumatic Brain Injury in a Rat Model
doi 10.3389/fnins.2022.832478
- 2,040 views
- 9 citations
ORIGINAL RESEARCH
Published on 11 Feb 2022
Bee Venom Effect on Glioblastoma Cells Viability and Gelatinase Secretion
doi 10.3389/fnins.2022.792970
- 4,036 views
- 7 citations
ORIGINAL RESEARCH
Published on 03 Feb 2022
Alzheimer’s Disease Enhanced Tonic Inhibition is Correlated With Upregulated Astrocyte GABA Transporter-3/4 in a Knock-In APP Mouse Model
doi 10.3389/fphar.2022.822499
- 3,781 views
- 12 citations
Published in
Frontiers in Neuroscience
- Neuropharmacology
Participating Journals
Frontiers in Neurology
NeuropharmacologyOffline
- 2.7 impact factor
- 4.9 citescore
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore
Frontiers in Psychiatry
NeuropharmacologyOffline
- 3.2 impact factor
- 6.2 citescore
Impact
- 61kTopic views
- 40kArticle views
- 19kArticle downloads